Phenylpropanolamine is commonly found in appetite suppressants and cough or cold remedies. Case reports have linked the use of products containing phenylpropanolamine to hemorrhagic stroke, often a ...

English-language, randomized, placebo-controlled trials of oral phenylpropanolamine in adults with extractable data on pulse or blood pressure were studied.

Claim: Drug products containing PPA (phenylpropanolamine) were pulled from the market due to FDA concerns over a possible connection to strokes. All drugs containing PHENYLPROPANOLAMINE (PPA) are ...

Find out how to take Chlorpheniramine and Phenylpropanolamine(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

Learn everything you need to know about Chlorpheniramine and Phenylpropanolamine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on ...

The FDA is taking steps to remove phenylpropanolamine hydrochloride from all drug products due to the risk of hemorrhagic stroke.

To the Editor: The request by the Food and Drug Administration (FDA) for the voluntary withdrawal of all products containing phenylpropanolamine on the basis of the data of Kernan et al. (Dec. 21 ...

Phenylpropanolamine (PPA) Market report provides depth analysis of the market recent developments and comprehensive competitive landscape created by the COVID19/CORONA Virus pandemic.

What is the basis of the recently released precaution regarding the pediatric use of drugs containing phenylpropanolamine?

Background: Phenylpropanolamine (PPA), a synthetic sympathomimetic agent, is a common ingredient in appetite suppressants and over-the-counter cough and cold remedies.

Phenylpropanolamine was removed from over-the-counter use in cold medicines because studies found the drug may put people at risk for hemorrhagic stroke.